Dulcin
Overview[edit]
Dulcin is a synthetic chemical compound that was historically used as an artificial sweetener. It is known for its sweet taste, which is approximately 250 times sweeter than sucrose. Dulcin was first synthesized in 1883 by the Polish chemist Joseph Berlinerbau.
Chemical Structure[edit]
Dulcin is chemically known as p-ethoxyphenylurea. Its molecular formula is C9H12N2O2. The compound consists of a phenyl group attached to an ethoxy group and a urea moiety. The presence of the ethoxy group contributes to its sweet taste.

History[edit]
Dulcin was introduced as a sweetening agent in the early 20th century. It gained popularity as a sugar substitute due to its intense sweetness and low caloric content. However, concerns about its safety led to a decline in its use.
Safety and Regulation[edit]
In the mid-20th century, studies raised concerns about the potential toxicity of Dulcin. Animal studies suggested that it might have carcinogenic properties, leading to its ban in several countries. The United States Food and Drug Administration (FDA) banned Dulcin in 1950.
Uses[edit]
Before its ban, Dulcin was used in various food and beverage products as a sugar substitute. It was particularly popular in dietary products aimed at individuals seeking to reduce caloric intake.
Related Compounds[edit]
Dulcin is part of a class of compounds known as artificial sweeteners. Other well-known artificial sweeteners include saccharin, aspartame, and sucralose. These compounds are used to provide sweetness without the calories associated with sugar.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian